A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial - Concepedia

Concepedia

Publication | Open Access

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

DOI Full Paper Access

42

Citations

36

References

2014

Year

Tjalf Ziemssen, Ovidiu Băjenaru, Adriana Carrá, Nina De Klippel, João Correia de Sá, Astrid Edland, Jette Lautrup Frederiksen, Olivier Heinzlef, Klimentini E. Karageorgiou, Rafael H. Lander Delgado,

Journal of Neurology

References

	Year	Citations

Page 1